Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oncologic Risk of Rectal Preservation Against Medical Advice After Chemoradiotherapy for Rectal Cancer: a Multicenter Comparative Study With Rectal Preservation as Supported by Surgeon

NCT03923309 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT03923309
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03923309 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oncologic Risk of Rectal Preservation Against Medical Advice After Chemoradiotherapy for Rectal Cancer: a Multicenter Comparative Study With Rectal Preservation as Supported by Surgeon
Lead sponsor
Seoul National University Hospital
Phase
Observational
Overall status
Completed
Start date
May 1, 2016
Completion date
December 30, 2017
Enrollment
142 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

chemoradiation, rectal cancer